OXFORD HEALTH NHS FOUNDATION TRUST
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 2011-02-01
- Employees
- 5K
- Market Cap
- -
Epilepsy Drug Ezogabine Shows Promise as Novel Depression Treatment by Targeting Brain Potassium Channels
Two recent studies reveal that ezogabine, an FDA-approved epilepsy medication, may effectively treat depression by normalizing hyperactivity in the brain's reward circuitry through KCNQ potassium channel modulation.
© Copyright 2025. All Rights Reserved by MedPath